In this special edition of the View, Kim A. Eagle, MD, MACC, talks with Dharam J. Kumbhani, MD, SM, FACC, Philippe Gabriel Steg, MD, FACC, and Payal Kohli, MD, FACC, about three of the major trials presented Monday, Aug. 28 during ESC Congress 2023.

The trials include ARAMIS (0:39), investigating potential treatments for acute myocarditis, RIGHT (3:22), exploring STEMI patients treated with primary PCI, evaluating the prolongation of anticoagulation after the procedure and ONCO-DVT (4:51), looking at the optimal duration of anticoagulation therapy (3 months vs. 12 months) with direct oral anticoagulant (edoxaban) for isolated distal deep vein thrombosis.

The ACC is providing coverage of the latest science being presented at ESC Congress 2023 in Amsterdam. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ESCCongress.

Clinical Topics: Anticoagulation Management, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Stable Ischemic Heart Disease, Vascular Medicine, Interventions and Vascular Medicine, Chronic Angina, Acute Coronary Syndromes, Arrhythmias and Clinical EP, Atherosclerotic Disease (CAD/PAD), Cardiac Surgery, Cardio-Oncology, Cardiovascular Care Team, Congenital Heart Disease and Pediatric Cardiology, COVID-19 Hub, Dyslipidemia, Geriatric Cardiology, Noninvasive Imaging, Pericardial Disease, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Sports and Exercise Cardiology, Valvular Heart Disease

Keywords: ESC Congress, ESC23, EaglesEyeView, ACC International, Myocarditis, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Blood Coagulation, Anticoagulants, Thiazoles, Pyridines, Thrombosis

< Back to Listings